Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans

NuklearMedizin

Volumn 46, Issue 5, 2007, Pages 175-180

  Thees, S ^a,b   Neumaier, B ^a   Glatting, Gerhard ^a   Deisenhofer, S ^a   Von Arnim, C A F ^a   Reske, S N ^a   Mottaghy, F M ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alzheimer; Biodistribution; BTA 1; Dosimetry; PET

Indexed keywords

AMYLOID BETA PROTEIN; CARBON 11; N METHYL 2 [4' (METHYLAMINOPHENYL)BENZOTHIAZOLE] C 11; N METHYL 2 HYDROXY [4' (METHYLAMINOPHENYL)BENZOTHIAZOLE] C 11; TRACER; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BONE MARROW; BRAIN; CARBON RADIOISOTOPES; FEMALE; GALLBLADDER; HEART; HUMANS; KIDNEY; LIVER; LUNG; MALE; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; TISSUE DISTRIBUTION; URINARY BLADDER;

EID: 35348994454     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1160/nukmed-0077     Document Type: Article

References (19)

1. rd Rev ed. American Psychiatric Publishing Inc. 1987.
2. Dewan MJ, Gupta S. Toward a definite diagnosis of Alzheimer's disease. Compr Psychiatry 1992; 33: 282-290.
3. Glatting G, Landmann M, Kull T et al. Internal radionuclide therapy: the ULMDOS software for treatment planning. Med Phys 2005; 32: 2399-2405.
4. Glatting G, Landmann M, Wunderlich A et al. Internal radionuclide therapy: A software for treatment planning using tomographic data. Nuklearmedizin 2006; 45: 269-272.
5. Guidelines abstracted from the American Academy of Neurology's Dementia Guidelines for Early Detection, Diagnosis, and Management of Dementia. J Am Geriatr Soc 2003; 51: 869-873.
6. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 2006; 13: 601-609.
7. Jobst KA, Barnetson LP, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 1997; 9 (Suppl 1): 191-222.
8. Klunk WE, Engler H, Nordberg A et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319.
9. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculation. Reston, VA: Society of Nuclear Medicine, 1991.
10. Lopresti BJ, Klunk WE, Mathis CA et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 2005; 46: 1959-1972.
11. 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 2003; 46: 2740-2754.
12. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
13. 11C-3′-Me- BTA-1) as potential radiotracers for in vivo imaging of amyloid plaques with positron emission tomography. Nuklearmedizin 2007; 46: in press.
14. Parsey RV, Sokol LO, Belanger MJ et al. Amyloid plaque imaging agent [C-11]-6-OH-BTA-1: biodistribution and radiation dosimetry in baboon. Nucl Med Commun 2005; 26: 875-880.
15. Price JC, Klunk WE, Lopresti BJ et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 2005; 25: 1528-1547.
16. Ravaglia G, Forti P, Maioli F et al. Incidence and etiology of dementia in a large elderly Italian population. Neurology 2005; 64: 1525-1530.
17. 11C]methyl triflate for beta-amyloid imaging in Alzheimer's Disease with PET. Appl Radiat Isot 2005; 62: 591-595.
18. Stabin MG, Siegel JA. Physical models and dose factors for use in internal dose assessment. Health Phys 2003; 85: 294-310.
19. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005; 46: 1023-1027.